Position in SEER
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$95,880
-$9,480 QoQ
Shares Held
57,072
-0.9% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SEER Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,555,077,811 across 347 Biotechnology names. SEER ranks #325 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in SEER
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $95,880 | 57,072 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $105,360 | 57,574 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $127,575 | 58,791 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $167,214 | 78,138 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $149,081 | 88,214 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $349,588 | 151,337 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $252,013 | 127,926 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $154,496 | 91,962 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $275,942 | 145,233 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $494,111 | 254,697 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $339,810 | 153,761 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $311,435 | 72,936 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $344,778 | 89,321 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $278,278 | 47,979 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $195,310 | 25,234 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $307,878 | 34,400 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $548,074 | 35,963 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $939,724 | 41,198 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $888,041 | 25,718 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,295,727 | 39,528 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $1,671,468 | 33,416 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,964 | 35 | Shares | Defined | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||